Compound Evidence File
#EC-2026-0417
KPV
Filed under Peptides. The bureau holds 78 laboratory returns for this compound from 29 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
29 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 6 | 10.0 | 9.9 | 10.0 | 23 May 2026 | 23 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| NUPEPS PeptidesCASE #VI-2026-0896 | X | 1 | 9.6 | 9.6 | 9.6 | 17 Dec 2024 | 17 Dec 2024 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 7 | 8.9 | 7.5 | 10.0 | 23 May 2026 | 23 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 7 | 8.9 | 8.3 | 9.5 | 21 May 2026 | 21 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 5 | 8.6 | 6.1 | 9.8 | 21 May 2026 | 21 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 6 | 8.5 | 6.7 | 9.3 | 23 May 2026 | 23 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 2 | 8.2 | 8.0 | 8.5 | 24 May 2026 | 24 May 2026 |
| Peptide PartnersCASE #VI-2026-0295 | X | 6 | 8.1 | 4.8 | 10.0 | 24 Apr 2025 | 19 Jan 2026 |
| Polaris PeptidesCASE #VI-2026-0839 | X | 6 | 7.5 | 6.1 | 9.4 | 28 Mar 2025 | 26 Jan 2026 |
| LiliPeptideCASE #VI-2026-0695 | X | 2 | 7.5 | 7.1 | 8.0 | 21 May 2025 | 19 Jan 2026 |
| Bio PepzCASE #VI-2026-0436 | X | 1 | 7.5 | 7.5 | 7.5 | 16 Mar 2025 | 16 Mar 2025 |
| Huaian Hanyou PeptideCASE #VI-2026-0297 | X | 1 | 7.4 | 7.4 | 7.4 | 13 Jun 2025 | 13 Jun 2025 |
| Allen Biotechnology Co ABCCASE #VI-2026-0709 | X | 3 | 6.9 | 5.9 | 8.3 | 8 Jul 2025 | 21 May 2026 |
| Accelerate LabsCASE #VI-2026-0686 | X | 2 | 6.9 | 6.8 | 7.0 | 11 Jun 2025 | 21 May 2026 |
| Verified PeptidesCASE #VI-2026-0407 | X | 3 | 6.7 | 5.7 | 8.2 | 27 Feb 2025 | 26 Jan 2026 |
| Xingruida XDRCASE #VI-2026-0898 | X | 1 | 6.4 | 6.4 | 6.4 | 8 Jul 2025 | 8 Jul 2025 |
| Huayi BiotechnologyCASE #VI-2026-0243 | X | 1 | 6.2 | 6.2 | 6.2 | 13 Feb 2025 | 13 Feb 2025 |
| Elite Research USACASE #VI-2026-0267 | X | 2 | 5.4 | 4.1 | 6.7 | 3 Jul 2025 | 26 Jan 2026 |
| YB PeptideCASE #VI-2026-0813 | X | 1 | 5.4 | 5.4 | 5.4 | 25 Apr 2025 | 25 Apr 2025 |
| Dankang BioHealthCASE #VI-2026-0775 | X | 1 | 5.0 | 5.0 | 5.0 | 9 Jun 2025 | 9 Jun 2025 |
| Amino AsylumCASE #VI-2026-0828 | X | 1 | 4.6 | 4.6 | 4.6 | 6 May 2025 | 6 May 2025 |
| Suaway Lab ResearchCASE #VI-2026-0488 | X | 2 | 4.3 | 3.6 | 5.0 | 27 Feb 2025 | 26 Jan 2026 |
| Xingtai Lesda TechnologyCASE #VI-2026-0381 | X | 1 | 4.0 | 4.0 | 4.0 | 20 Jun 2025 | 20 Jun 2025 |
| Guangzhou Yuao TradingCASE #VI-2026-0787 | X | 1 | 3.2 | 3.2 | 3.2 | 13 Feb 2025 | 13 Feb 2025 |
| HybiopeptidesCASE #VI-2026-0305 | X | 1 | 3.1 | 3.1 | 3.1 | 13 Feb 2025 | 13 Feb 2025 |
| Swiss ChemsCASE #VI-2026-0030 | X | 1 | 2.8 | 2.8 | 2.8 | 6 May 2025 | 6 May 2025 |
| Coffee and PeppersCASE #VI-2026-0274 | X | 1 | 1.6 | 1.6 | 1.6 | 8 Jul 2025 | 8 Jul 2025 |
| Hebei Chengtong TechnologyCASE #VI-2026-0520 | X | 1 | 1.4 | 1.4 | 1.4 | 7 May 2025 | 7 May 2025 |
Open any subject to view the batch-level evidence for KPV alone.